Pancreatic Cancer Research

ResearcherSoochow UniversityActive in the last 2 years

Xuemin Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1818-9206; OpenAlex author ID A5101957488. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. IL15RA-STAT3-GPX4/ACSL3 signaling leads to ferroptosis resistance in pancreatic cancer. Last author DOI 10.3724/abbs.2024153↗
  2. A positive feedback loop of ARF6 activates ERK1/2 signaling pathway via DUSP6 silencing to promote pancreatic cancer progression. Last author DOI 10.3724/abbs.2022111↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaowu Xu · 2 shared papers, 2022–2024 · strength 0.35
  2. Yue Zhang · 2 shared papers, 2022–2024 · strength 0.35
  3. Di Wu · 1 shared paper, 2024 · strength 0.20
  4. Xianjun Yu · 1 shared paper, 2024 · strength 0.20
  5. Zhiliang Wang · 1 shared paper, 2024 · strength 0.20
  6. Yi Qin · 1 shared paper, 2024 · strength 0.20
  7. Zekun Lu · 1 shared paper, 2022 · strength 0.15
  8. Bingkai Xiao · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.